Cargando…
Tenebrio molitor as a Simple and Cheap Preclinical Pharmacokinetic and Toxicity Model
The progression of drugs into clinical phases requires proper toxicity assessment in animals and the correct identification of possible metabolites. Accordingly, different animal models are used to preliminarily evaluate toxicity and biotransformations. Rodents are the most common models used to pre...
Autores principales: | Brai, Annalaura, Poggialini, Federica, Vagaggini, Chiara, Pasqualini, Claudia, Simoni, Sauro, Francardi, Valeria, Dreassi, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917132/ https://www.ncbi.nlm.nih.gov/pubmed/36768618 http://dx.doi.org/10.3390/ijms24032296 |
Ejemplares similares
-
Progress towards Adjuvant Development: Focus on Antiviral Therapy
por: Brai, Annalaura, et al.
Publicado: (2023) -
Sweet Cherry Extract as Permeation Enhancer of Tyrosine Kinase Inhibitors: A Promising Prospective for Future Oral Anticancer Therapies
por: Poggialini, Federica, et al.
Publicado: (2023) -
Antihypertensive, cardio- and neuro-protective effects of Tenebrio molitor (Coleoptera: Tenebrionidae) defatted larvae in spontaneously hypertensive rats
por: Pessina, Federica, et al.
Publicado: (2020) -
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme
por: Poggialini, Federica, et al.
Publicado: (2023) -
Serum Metabolomics and Proteomics to Study the Antihypertensive Effect of Protein Extracts from Tenebrio molitor
por: Stella, Roberto, et al.
Publicado: (2022)